Correlation Between Computer Modelling and Rakovina Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Computer Modelling and Rakovina Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Computer Modelling and Rakovina Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Computer Modelling Group and Rakovina Therapeutics, you can compare the effects of market volatilities on Computer Modelling and Rakovina Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Computer Modelling with a short position of Rakovina Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Computer Modelling and Rakovina Therapeutics.

Diversification Opportunities for Computer Modelling and Rakovina Therapeutics

-0.31
  Correlation Coefficient

Very good diversification

The 3 months correlation between Computer and Rakovina is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Computer Modelling Group and Rakovina Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rakovina Therapeutics and Computer Modelling is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Computer Modelling Group are associated (or correlated) with Rakovina Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rakovina Therapeutics has no effect on the direction of Computer Modelling i.e., Computer Modelling and Rakovina Therapeutics go up and down completely randomly.

Pair Corralation between Computer Modelling and Rakovina Therapeutics

Assuming the 90 days trading horizon Computer Modelling Group is expected to under-perform the Rakovina Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Computer Modelling Group is 8.74 times less risky than Rakovina Therapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The Rakovina Therapeutics is currently generating about 0.24 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Rakovina Therapeutics on October 10, 2024 and sell it today you would earn a total of  5.00  from holding Rakovina Therapeutics or generate 41.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Computer Modelling Group  vs.  Rakovina Therapeutics

 Performance 
       Timeline  
Computer Modelling 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Computer Modelling Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Rakovina Therapeutics 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Rakovina Therapeutics are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Rakovina Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Computer Modelling and Rakovina Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Computer Modelling and Rakovina Therapeutics

The main advantage of trading using opposite Computer Modelling and Rakovina Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Computer Modelling position performs unexpectedly, Rakovina Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rakovina Therapeutics will offset losses from the drop in Rakovina Therapeutics' long position.
The idea behind Computer Modelling Group and Rakovina Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Stocks Directory
Find actively traded stocks across global markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets